Literature DB >> 32609039

Early Palliative Care Services and End-of-Life Care in Medicare Beneficiaries with Hematologic Malignancies: A Population-Based Retrospective Cohort Study.

Vinay B Rao1, Emmanuelle Belanger2, Pamela C Egan3, Thomas W LeBlanc4, Adam J Olszewski5.   

Abstract

Background: Patients with hematologic malignancies (HM) often receive aggressive care at the end of life (EOL). Early palliative care (PC) has been shown to improve EOL care outcomes, but its benefits are less established in HM than in solid tumors.
Objectives: We sought to describe the use of billed PC services among Medicare beneficiaries with HM. We hypothesized that receipt of early PC services (rendered >30 days before death) may be associated with less aggressive EOL care. Design: Retrospective cohort analysis Setting/Subjects: Using the Surveillance, Epidemiology, and End Results-Medicare registry, we studied patients with leukemia, lymphoma, myeloma, myelodysplastic syndrome, or myeloproliferative neoplasm who died between 2001 and 2015. Measurements: We described trends in the use of PC services and evaluated the association between early PC services and metrics of EOL care aggressiveness.
Results: Among 139,191 decedents, the proportion receiving PC services increased from 0.4% in 2001 to 13.3% in 2015. Median time from first encounter to death was 10 days and 84.3% of encounters occurred during hospitalizations. In patients who survived >30 days from diagnosis (N = 120,741), the use of early PC services was more frequent in acute leukemia, women, and black patients, among other characteristics. Early PC services were associated with increased hospice use and decreased health care utilization at the EOL.
Conclusion: Among patients with HM, there was an upward trend in PC services, and early PC services were associated with less aggressive EOL care. Our results support the need for prospective trials of early PC in HM.

Entities:  

Keywords:  Medicare; Surveillance, Epidemiology, and End Results; end-of-life care; hematologic malignancy; palliative care; population

Mesh:

Year:  2020        PMID: 32609039      PMCID: PMC8020510          DOI: 10.1089/jpm.2020.0006

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  30 in total

1.  Payment code for hospital-based palliative care: help or hindrance?

Authors:  C F Capello; D E Meier; C K Cassel
Journal:  J Palliat Med       Date:  1998       Impact factor: 2.947

2.  The impact of inpatient palliative care on end-of-life care among older trauma patients who die after hospital discharge.

Authors:  Elizabeth J Lilley; Katherine C Lee; John W Scott; Nicole J Krumrei; Adil H Haider; Ali Salim; Rajan Gupta; Zara Cooper
Journal:  J Trauma Acute Care Surg       Date:  2018-11       Impact factor: 3.313

3.  Validation of the V66.7 Code for Palliative Care Consultation in a Single Academic Medical Center.

Authors:  May Hua; Guohua Li; Caitlin Clancy; R Sean Morrison; Hannah Wunsch
Journal:  J Palliat Med       Date:  2016-12-07       Impact factor: 2.947

4.  Validation of disability status, a claims-based measure of functional status for cancer treatment and outcomes studies.

Authors:  Amy J Davidoff; Lisa D Gardner; Ilene H Zuckerman; Franklin Hendrick; Xuehua Ke; Martin J Edelman
Journal:  Med Care       Date:  2014-06       Impact factor: 2.983

Review 5.  Palliative and End-of-Life Care for Patients With Hematologic Malignancies.

Authors:  Areej El-Jawahri; Ashley M Nelson; Tamryn F Gray; Stephanie J Lee; Thomas W LeBlanc
Journal:  J Clin Oncol       Date:  2020-02-05       Impact factor: 44.544

6.  Effect of Palliative Care on Aggressiveness of End-of-Life Care Among Patients With Advanced Cancer.

Authors:  Daniel P Triplett; Wendi G LeBrett; Alex K Bryant; Andrew R Bruggeman; Rayna K Matsuno; Lindsay Hwang; Isabel J Boero; Eric J Roeland; Heidi N Yeung; James D Murphy
Journal:  J Oncol Pract       Date:  2017-08-22       Impact factor: 3.840

7.  Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center.

Authors:  Nada Fadul; Ahmed Elsayem; J Lynn Palmer; Egidio Del Fabbro; Kay Swint; Zhijun Li; Valerie Poulter; Eduardo Bruera
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

8.  Filling the gaps: Preparing nurse practitioners for hospitalist practice.

Authors:  Sharon E Bryant
Journal:  J Am Assoc Nurse Pract       Date:  2018-01       Impact factor: 1.165

9.  Barriers to the Collaboration Between Hematologists and Palliative Care Teams on Relapse or Refractory Leukemia and Malignant Lymphoma Patients' Care: A Qualitative Study.

Authors:  Miharu Morikawa; Yuki Shirai; Ryota Ochiai; Kiyoshi Miyagawa
Journal:  Am J Hosp Palliat Care       Date:  2015-10-22       Impact factor: 2.500

10.  Palliative care specialists' perceptions concerning referral of haematology patients to their services: findings from a qualitative study.

Authors:  Dorothy McCaughan; Eve Roman; Alexandra G Smith; Anne C Garry; Miriam J Johnson; Russell D Patmore; Martin R Howard; Debra A Howell
Journal:  BMC Palliat Care       Date:  2018-02-21       Impact factor: 3.234

View more
  3 in total

Review 1.  Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?

Authors:  Thomas M Kuczmarski; Oreofe O Odejide
Journal:  Curr Hematol Malig Rep       Date:  2021-04-16       Impact factor: 3.952

Review 2.  Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients.

Authors:  Mengyang Di; Scott F Huntington; Adam J Olszewski
Journal:  Oncologist       Date:  2020-12-09       Impact factor: 5.837

3.  Evaluating palliative opportunities in pediatric patients with leukemia and lymphoma.

Authors:  Emily J Labudde; Nicholas P DeGroote; Susie Smith; Jonathan Ebelhar; Kristen E Allen; Sharon M Castellino; Karen Wasilewski-Masker; Katharine E Brock
Journal:  Cancer Med       Date:  2021-03-22       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.